Nagarjun Bolem

Nagarjun Bolem

Auto-generated profile, based on publicly available information

Nagarjun Bolem

Department of Surgery, Division of Neurosurgery National University Hospital Singapore Singapore

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2023 in Bioengineering & Translational Medicine
Verified
Journal Article
Open access
XLXin Yuan Lim
Xin Yuan Lim
SCSharah Mae Capinpin
Sharah Mae Capinpin
NBNagarjun Bolem
Nagarjun Bolem
AFAaron Foo
Aaron Foo
GYGeorge Yip
George Yip
Daniel Boon Loong TehDaniel Boon Loong Teh
Daniel Boon Loong Teh
Glioblastoma multiforme (GBM) is an aggressive brain tumor with poor prognosis and high mortality, with no curative treatment to date as limited trafficking across the blood–brain barrier (BBB) combined with tumor heterogeneity often leads to therapeutic failure. Although modern medicine poses a wide range of drugs that are otherwise efficacious in treating other tumors, they often do not achieve therapeutic concentrations in the brain, hence driving the need for more effective drug delivery strategies. Nanotechnology, an interdisciplinary field, has been gaining immense popularity in recent years for remarkable advancements such as nanoparticle (NP) drug carriers, which possess extraordinary versatility in modifying surface coatings to home in on target cells, including those beyond the BBB. In this review, we will be highlighting recent developments in biomimetic NPs in GBM therapy and how these allowed us to overcome the physiological and anatomical challenges that have long plagued GBM treatment.

1 March 2020 in Asian Journal of Neurosurgery
Verified
Journal Article
Open access
NBNagarjun Bolem
Nagarjun Bolem
VNVincent D W Nga
Vincent D W Nga
NCNing Chou
Ning Chou
TYTseng Yeo
Tseng Yeo
JLJeremy Lin
Jeremy Lin
Vijay sharmaVijay sharma
Vijay sharma
Moyamoya disease (MMD) is an incompletely understood malady that affects many age groups, primarily in a bimodal age distribution. We present a patient with the association of type 1 diabetes mellitus (type 1 DM) and MMD followed by a review of the existing literature. We found five papers that describe this association, in the form of one case report, one case series, and three retrospective reviews. Despite a poor understanding of the underlying pathophysiology, a clear association between autoimmune conditions and MMD appears to exist. Clinicians who manage such patients ought to be vigilant and have a high index of suspicion when young patients with type 1 DM present with new onset of neurological symptoms.

21 July 2020 in Advanced Materials
Verified
Journal Article
Open access
PDF file
Daniel Boon Loong TehDaniel Boon Loong Teh
Daniel Boon Loong Teh
ABAkshaya Bansal
Akshaya Bansal
CCChou Chai
Chou Chai
TTTan Boon Toh
Tan Boon Toh
RTRobert Alan Jappy Tucker
Robert Alan Jappy Tucker
BKBrian K. Kennedy
Brian K. Kennedy
An upconversion biocompatible implant is the first step of translating decades‐old near‐infrared nanotransducer research into wireless phototherapeutic devices that can be implanted underneath the skin. The use of a hydrogel and cladding results in an upconversion optical fiber that is able to upconvert in a flexible manner and even transmit NIR at maximal bending is described by Kah‐Leong Lim, Yong Zhang, Brian K. Kennedy, and co‐workers in article number 2001459. This concept is applicable to various needs of wireless phototherapeutics. With better designs in the future, upconversion implants will be able to be translated from the bench to the bedside.